Here are relevant reports on : high-throughput-screening-market

• Drug Screening Market by Offering [On-site Testing, Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)], Sample (Blood, Urine, Hair), Drug (Cannabis, Alcohol), End User (Workplace, Law, Hospitals) - Global Forecast to 2030

  The global drug screening market, valued at US$8.92 billion in 2024, stood at US$10.36 billion in 2025 and is projected to advance at a resilient CAGR of 15.5% from 2025 to 2030, culminating in a forecasted valuation of US$21.29 billion by the end of the period. The market for drug screening is being fueled by growing workplace and clinical testing programs, an increased need for opioid/polysubstance monitoring, and an increased use of rapid point-of-care technologies and advanced confirmatory testing (LC MS/MS) systems.

  • Published: February 2026
  • Price: $ 4950
  • TOC Available:

• Automotive Shredded Residue (ASR) Market by Application (Landfill, Energy recovery, Recycling), Composition, Technology ( Air classification, Optical sorting, Magnetic separation, Eddy current separation, Screening) and Region - Global Forecast to 2028

  The automotive shredded residue (ASR) market is expected to grow from USD 1.1 billion in 2023 to USD 1.6 billion by 2028, at a CAGR of 6.6% during the forecast period. The key players in this market are Galloo (Belgium), MBA Polymers Inc. (US), PLANIC (Japan), Sims Limited (Australia), Axion Ltd (UK), SRW Metal Float GmbH (Germany), Machinex Industries Inc. (Canada), Wendt Corporation (US), Binder+Co. (Austria), CP Manufacturing Inc. (US), Tomra Systems ASA (Norway), BT-Wolfgang Binder GmbH (Austria), Agilyx (US), Steinert (Germany).

  • Published: September 2023
  • Price: $ 4950
  • TOC Available:

• Mental Health Apps Market by Platform (Android, iOS), Application (Depression, Meditation, Stress, Trauma), Function (Screening, Consultation, Prescription, Treatment, Monitoring, Coaching), End User (Provider, Patient, Employer) - Global Forecast to 2030

  The Mental Health Apps market, valued at US$8.21 billion in 2024, stood at US$9.94 billion in 2025 and is projected to advance at a resilient CAGR of 18.0% from 2025 to 2030, culminating in a forecasted valuation of US$22.73 billion by the end of the period. The mental health apps market is growing rapidly, driven by advancements in digital technologies such as artificial intelligence, data analytics, and mobile health platforms.

  • Published: November 2026
  • Price: $ 4950
  • TOC Available:

• CRISPR Market by Offering (Products [Kits, Enzymes, Libraries], Services [gRNA Synthesis, Cell Line Development, Screening, Validation]), Application (Drug Discovery, Development, Agriculture), End User, Competition, Region - Global Forecast to 2031

  The global CRISPR market is projected to reach USD 6.12 billion by 2031, growing at a CAGR of 12.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: October 2026
  • Price: $ 4950
  • TOC Available:

• Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023

  The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.

  • Published: May 2018
  • Price: $ 4950
  • TOC Available:

• AI in Chemicals Market by Hardware (Accelerators, Processors, Memory, Network), Software (Dashboard & Analytics, Process Simulation, Laboratory Management, Chemical Property Prediction, Virtual Screening), Technology (ML, NLP) - Global Forecast to 2029

  The global market for the AI in chemicals market is projected to reach USD 3.8 billion by 2029 at a CAGR of 39.2% during the forecast period. The major AI in chemicals providers include IBM (US), Microsoft (US), Schneider Electric (France), AWS (US), Google (US), SAP (Germany), NVIDIA (US), C3.ai (US), GE Vernova (US), Siemens (Germany), Hexagon (Sweden), Engie Impact (US), TrendMiner (Belgium), Xylem (US), NobleAI (US), Iktos (France), Kebotix (US), Uptime AI (US), Canvass AI (Canada), Nexocode (Poland), SandboxAQ (US), Deepmatter (England), Zapata AI (US), Citirne Informatics (US), Chemical.AI (China), Augury (Israel), Intellegens (UK), Ripik.AI (India), Tractian (US), Polymerize (Singapore), ScienceDesk (Germany), OptiSol Business Solutions (India), NuWater (Africa) and VROC (Australia). These companies have used both organic and inorganic growth strategies such as product launches, acquisitions, and partnerships to strengthen their position in the AI in chemicals market.

  • Published: May 2024
  • Price: $ 4950
  • TOC Available:

• AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030

  The global AI in Precision Medicine market, valued at US$0.60 billion in 2023, stood at US$0.78 billion in 2024 and is projected to advance at a resilient CAGR of 30.7% from 2024 to 2030, culminating in a forecasted valuation of US$3.92 billion by the end of the period. Growth in precision medicine, AI’s efficiency in drug discovery, integration of Real-World Evidence (RWE) in emerging markets to drive the market significantly.

  • Published: November 2024
  • Price: $ 4950
  • TOC Available:

• Carrier Screening Market by Product and Service, Type (Expanded (Customized, Predesigned) Targeted Diseases, Medical condition (Hematologic, Pulmonary), Technology (DNA Sequencing, PCR), End User, Region - Global Forecast to 2028

  The global carrier screening market, valued at US$1.8 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 19.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.4 billion by the end of the period. The expansion of this market is majorly due to the development and availability of expanded carrier screening panels that cover a wide range of genetic conditions contribute to the market's growth.

  • Published: January 2024
  • Price: $ 4950
  • TOC Available:

• In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023

  The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

  • Published: April 2018
  • Price: $ 11000
  • TOC Available:

• Anti-money Laundering (AML) Market by Offering (Solutions (KYC/CDD & Sanctions Screening, Transaction Monitoring, Case Management & Reporting)), End User (Banks & Financial Institutes, Insurance, Gaming & Gambling), and Region - Global Forecast to 2030

  The global AML market size is projected to grow from USD 4.13 billion in 2025 to USD 9.38 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 17.8% during the forecast period. LexisNexis (US), Oracle (US), FIS (US), Fiserv (US), Jumio (US), NICE Actimize (US), SAS Institute (US), GB Group PLC (UK), FICO (US), ACI Worldwide (US), Experian (Ireland), Wolters Kluwer (Netherlands), Transunion (US), ComplyAdvantage (UK), Friss (Netherlands), Nelito Systems (India), Comarch (Poland), Allsec Technologies (India), Dixtior (Portugal), Temenos (Switzerland), TCS (India), Featurespace (UK), Feedzai (Portugal), Napier AI (UK), Tier1 Financial Solutions (Canada), Finacus Solutions (India), SymphonyAI (US), IDMERIT (US), IMTF (Switzerland), Innovative Systems (US), Sedicii (Ireland), Trulioo (Canada), NameScan (Australia), DataVisor (US), and Gurucul (US) are the key players and other players in the AML market.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS
• NEXT
• LAST

Records 21 to 30 of 50